SOUTH Africa and India planned to renew their bid at a two-day meeting to waive rules of the WTO's Trade-Related Aspects of Intellectual Property (TRIPS) agreement, a move that would allow generic or other manufacturers to make more vaccines. Their proposal is backed by dozens of largely developing countries at the WTO, but opposed by Western countries including Britain, Switzerland, EU nations and the United States, which have large domestic pharmaceutical industries. Proposals need backing by a consensus of the WTO's 164 members to pass. The issue was set to come up at the WTO's TRIPS Council on Wednesday afternoon.…